共 47 条
Epigenetic Down-Regulation of the Tumor Suppressor Gene PRDM1/Blimp-1 in Diffuse Large B Cell Lymphomas A Potential Role of the MicroRNA Let-7
被引:51
作者:
Nie, Kui
[1
]
Zhang, Taotao
[1
]
Allawi, Hatim
[2
]
Gomez, Mario
[1
]
Liu, Yifang
[1
]
Chadburn, Amy
[1
]
Wang, Y. Lynn
[1
]
Knowles, Daniel M.
[1
]
Tam, Wayne
[1
]
机构:
[1] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA
[2] Third Wave Technol, Madison, WI USA
关键词:
TRANSCRIPTIONAL REPRESSOR BLIMP-1;
BURKITT-LYMPHOMA;
PRDM1;
GENE;
LET-7;
DIFFERENTIATION;
EXPRESSION;
LYMPHOCYTES;
MICRORNAS;
IDENTIFICATION;
INACTIVATION;
D O I:
10.2353/ajpath.2010.091291
中图分类号:
R36 [病理学];
学科分类号:
100104 ;
摘要:
PRDM1/Blimp-1, a master regulator for B cell terminal differentiation, is a putative tumor suppressor in diffuse large B cell lymphomas (DLBCL). Inactivating mutations of PRDM1 have been previously identified in a subset of nongerminal center B cell like (GCB) DLBCL. We investigated the presence of alternative mechanisms of down-regulating PRDM1 in a cohort of 25 primary DLBCL and six DLBCL cell lines. While some DLBCL, predominantly the GCB-type, showed low levels of both PRDM1 a mRNA and protein, presumably as a result of direct transcription repression, discordant expressions between the two were identified in a subset of DLBCL without PRDM1 mutations, the primarily non-GCB type, consistent with translational down-regulation. This subset of DLBCL. exhibits relatively high PRDM1 a mRNA levels but low levels of PRDM1. Data obtained from expression analysis, luciferase reporter assays, and transfection experiments support a role of targeting of PRDM1 by microRNA let-7 family in mediating this down-regulation. Let-7, in particular let-7b, is overexpressed in DLBCL relative to normal GCB cells, suggesting that it is deregulated. Thus, abnormal epigenetic down-regulation of PRDM1 by let-7 and other microRNAs may represent an alternative mechanism of reducing normal PRDM1 function in a subset of DLBCL with relatively high PRDM1 a mRNA expression and unmutated PRDM1. These findings provide further evidence for an important role of impairment of terminal B cell differentiation in DLBCL pathogenesis. (Am J Pathol 2010, 177:1470-1479: DOI: 10.2353/ajpath.2010.091291)
引用
收藏
页码:1470 / 1479
页数:10
相关论文